Shandong New Time Pharmaceutical Co., LTD

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Cervical cancer1 trial
• High blood pressure1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Enrolling by invitation2 trials

Lead sponsor

• Shandong New Time Pharmaceutical Co., LTD2 trials

Running trials

• Enrolling by invitation

  A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents

  NCT06863987· Phase 3· Shandong New Time Pharmaceutical Co., LTD· Source

• Enrolling by invitation

  A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

  NCT06755515· Phase 2/3· Shandong New Time Pharmaceutical Co., LTD· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Cervical cancer1 recruiting
• High blood pressure1 recruiting